Loading interface...

Banocide 120 mg Syrup

Manufactured byGlaxosmithkline Pharmaceuticals Ltd.
Description

Banocide 120 mg Syrup is an antiparasitic agent used for the prevention and treatment of worm infections which may cause severe swelling of the arms, legs, and genitals. It may also be used for the prevention and treatment of worm infections of the eye which may cause blindness and worm infections which may cause joint, connective tissue, nervous system, or breathing disorders. It is not recommended to prevent or treat the infections caused by pinworms and tapeworms.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Substitutes

List of substitutes for Banocide 120 mg Syrup

Hetrazan 120 mg Syrup
Pfizer Ltd.

Side effects

Major & minor side effects for Banocide 120 mg Syrup

  • Fever
  • Tender, swollen glands in the neck
  • Skin rash
  • Visual disturbances
  • Nausea
  • Dizziness

Uses of Banocide 120 mg Syrup

What is it prescribed for?

  • Lymphatic Filariasis
  • Loiasis
  • Toxocariasis
  • Tropical pulmonary eosinophilia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    There is no clinically established data available on the duration of action of Banocide 120 mg Syrup.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women. Your doctor will prescribe an alternative medicine based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women. Your doctor will prescribe an alternative medicine based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to Banocide 120 mg Syrup.

Onchocerciasis (River blindness)

Patients being treated with Banocide 120 mg Syrup for onchocerciasis may experience Mazzotti reaction which may be characterized by fever, headache, dizziness, vomiting, lymphangitis, or asthmatic attacks. These patients should be monitored closely and supportive care should be initiated based on the severity of the reaction.

Pediatric use

Children under 10 years of age should receive half the total adult dose. The use of this medicine is not recommended for children under 2 years of age.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women. Your doctor will prescribe an alternative medicine based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women. Your doctor will prescribe an alternative medicine based on your clinical condition.
General warnings

Prolonged use

Prolonged use of Banocide 120 mg Syrup may cause tunnel vision, night blindness, or loss of vision.

Renal impairement

For patients with kidney diseases or renal impairment, appropriate dose adjustments should be done to prevent adverse effects.

Use in severely ill patients

Do not use this medicine in severely ill patients with other acute diseases until their recovery.

Epilepsy

This medicine should be used with caution in patients with a history of epilepsy due to the increased risk of convulsions or seizures.

Cardiac disease

Use of this medicine is not recommended in patients with cardiac diseases due to the increased risk of severe side effects like tachycardia.

Other medicines

Report the active use of all other medicines including herbs and supplements to the doctor before receiving this medicine.

Missed Dose

If a dose of Banocide 120 mg Syrup is missed, take the dose as soon as you remember it. If it is almost the time for the next dose, skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Antimalarial drugs

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Do not take more than what is prescribed or share this medication with other people. Complete the prescribed course of therapy. Do not stop the therapy before completion even if the symptoms improve or disappear.
Miscelleneous

To be taken immediately after food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Banocide 120 mg Syrup acts on both the movement of the worms and the surface layer of the worms, making them easier to kill. The worms are then killed by the immune system of the body.
Legal Status

Approved

Unknown

Unknown

Approved

Classification

Category

Anthelmintics

Schedule

N/A

Diethylcarbamazine - DrugBank [Internet]. Drugbank.ca. 2017 [cited 19 July 2017]. Available from:

https://www.drugbank.ca/drugs/DB00711

Carbamazepine and derivatives [Internet]. Snomedbrowser.com. 2017 [cited 19 July 2017]. Available from:

http://www.snomedbrowser.com/Codes/Details/412037008

WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Helminths: Lymphatic filariasis: Diethylcarbamazine [Internet]. Apps.who.int. 2017 [cited 19 July 2017]. Available from:

http://apps.who.int/medicinedocs/en/d/Jh2922e/3.5.1.html#Jh2922e.3.5.1

WHOCC - ATC/DDD Index [Internet]. Whocc.no. 2017 [cited 19 July 2017]. Available from:

https://www.whocc.no/atc_ddd_index/
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Jul 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.